RhumbLine Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Sell |
237,730
-183
| -0.1% | -$1.48K | ﹤0.01% | 1907 |
|
|
2025
Q1 | $1.99M | Buy |
237,913
+5,649
| +2% | +$47.3K | ﹤0.01% | 1812 |
|
|
2024
Q4 | $1.84M | Buy |
232,264
+7,875
| +4% | +$62.4K | ﹤0.01% | 1927 |
|
|
2024
Q3 | $1.87M | Sell |
224,389
-8,828
| -4% | -$73.4K | ﹤0.01% | 1948 |
|
|
2024
Q2 | $1.48M | Buy |
233,217
+30,286
| +15% | +$192K | ﹤0.01% | 2040 |
|
|
2024
Q1 | $1.23M | Sell |
202,931
-9,860
| -5% | -$59.8K | ﹤0.01% | 2136 |
|
|
2023
Q4 | $1.29M | Buy |
212,791
+13,386
| +7% | +$81.3K | ﹤0.01% | 2135 |
|
|
2023
Q3 | $841K | Buy |
199,405
+623
| +0.3% | +$2.63K | ﹤0.01% | 2300 |
|
|
2023
Q2 | $616K | Buy |
198,782
+36,597
| +23% | +$113K | ﹤0.01% | 2558 |
|
|
2023
Q1 | $225K | Buy |
162,185
+1,672
| +1% | +$2.32K | ﹤0.01% | 2710 |
|
|
2022
Q4 | $319K | Buy |
160,513
+4,862
| +3% | +$9.66K | ﹤0.01% | 2655 |
|
|
2022
Q3 | $314K | Buy |
155,651
+8,930
| +6% | +$18K | ﹤0.01% | 2708 |
|
|
2022
Q2 | $467K | Buy |
146,721
+2,139
| +1% | +$6.81K | ﹤0.01% | 2531 |
|
|
2022
Q1 | $603K | Sell |
144,582
-13,640
| -9% | -$56.9K | ﹤0.01% | 2340 |
|
|
2021
Q4 | $758K | Buy |
158,222
+5,688
| +4% | +$27.3K | ﹤0.01% | 2328 |
|
|
2021
Q3 | $815K | Buy |
152,534
+2,938
| +2% | +$15.7K | ﹤0.01% | 2327 |
|
|
2021
Q2 | $766K | Sell |
149,596
-4,654
| -3% | -$23.8K | ﹤0.01% | 2363 |
|
|
2021
Q1 | $1.04M | Sell |
154,250
-6,793
| -4% | -$45.7K | ﹤0.01% | 2177 |
|
|
2020
Q4 | $736K | Buy |
161,043
+7,290
| +5% | +$33.3K | ﹤0.01% | 2273 |
|
|
2020
Q3 | $597K | Sell |
153,753
-23,490
| -13% | -$91.2K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $844K | Buy |
177,243
+22,237
| +14% | +$106K | ﹤0.01% | 2116 |
|
|
2020
Q1 | $539K | Buy |
155,006
+7,987
| +5% | +$27.8K | ﹤0.01% | 2132 |
|
|
2019
Q4 | $709K | Buy |
147,019
+16,872
| +13% | +$81.4K | ﹤0.01% | 2225 |
|
|
2019
Q3 | $377K | Sell |
130,147
-745
| -0.6% | -$2.16K | ﹤0.01% | 2450 |
|
|
2019
Q2 | $938K | Buy |
130,892
+7,042
| +6% | +$50.5K | ﹤0.01% | 2086 |
|
|
2019
Q1 | $1.76M | Sell |
123,850
-1,460
| -1% | -$20.7K | ﹤0.01% | 1788 |
|
|
2018
Q4 | $1.7M | Buy |
125,310
+37,713
| +43% | +$510K | ﹤0.01% | 1747 |
|
|
2018
Q3 | $1.94M | Sell |
87,597
-5,685
| -6% | -$126K | ﹤0.01% | 1676 |
|
|
2018
Q2 | $1.53M | Buy |
+93,282
| New | +$1.53M | ﹤0.01% | 1815 |
|